Covered recipient · General Payments record
ERICK R HERNANDEZ-CAMPOS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$522.70
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $415.10 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $268.34 | 14 |
| Acerta Pharma LLC | $146.76 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $123.77 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105616945 | CMS |
| AstraZeneca Pharmaceuticals LP | $7.25 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105601175 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.74 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105546321 | CMS |
| Novo Nordisk Inc | $24.28 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100339952 | CMS |
| Novo Nordisk Inc | $8.37 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100543926 | CMS |
| Novo Nordisk Inc | $13.55 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100253504 | CMS |
| Novo Nordisk Inc | $8.71 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100478832 | CMS |
| Novo Nordisk Inc | $11.10 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100377365 | CMS |
| Novo Nordisk Inc | $5.37 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100497447 | CMS |
| Novo Nordisk Inc | $8.43 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100330026 | CMS |
| Novo Nordisk Inc | $12.73 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100378041 | CMS |
| Novo Nordisk Inc | $121.86 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100444641 | CMS |
| Novo Nordisk Inc | $10.63 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100381015 | CMS |
| Novo Nordisk Inc | $7.17 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100351708 | CMS |
| Novo Nordisk Inc | $3.90 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100423294 | CMS |
| Novo Nordisk Inc | $24.04 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100573206 | CMS |
| Novo Nordisk Inc | $8.20 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100537269 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.